These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29227201)
61. Clostridium difficile in an Urban, University-Affiliated Long-Term Acute-Care Hospital. Jacob J; Wu J; Han J; Nelson DB Infect Control Hosp Epidemiol; 2017 Mar; 38(3):294-299. PubMed ID: 27923419 [TBL] [Abstract][Full Text] [Related]
62. High frequency of nonadherence to Clostridium difficile treatment guidelines. McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627 [TBL] [Abstract][Full Text] [Related]
63. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections. Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436 [TBL] [Abstract][Full Text] [Related]
64. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection. Pettit NN; DePestel DD; Fohl AL; Eyler R; Carver PL Pharmacotherapy; 2015 Feb; 35(2):119-26. PubMed ID: 25689243 [TBL] [Abstract][Full Text] [Related]
65. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients. Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419 [TBL] [Abstract][Full Text] [Related]
66. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus. Clohessy P; Merif J; Post JJ Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250 [TBL] [Abstract][Full Text] [Related]
67. Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis. Lightner AL; Tse CS; Quinn K; Bergquist JR; Enders F; Pendegraft R; Khanna S; Raffals L Inflamm Bowel Dis; 2017 Jul; 23(7):1195-1201. PubMed ID: 28410344 [TBL] [Abstract][Full Text] [Related]
68. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection. Lam SW; Bass SN; Neuner EA; Bauer SR Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633 [TBL] [Abstract][Full Text] [Related]
69. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital. Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905 [TBL] [Abstract][Full Text] [Related]
70. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China. Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295 [TBL] [Abstract][Full Text] [Related]
71. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504 [TBL] [Abstract][Full Text] [Related]
72. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs. Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421 [TBL] [Abstract][Full Text] [Related]
73. Outcomes of Continuous Enteral Vancomycin Infusion in Intensive Care Unit Patients: A Novel Treatment Modality for Severe Clostridium Difficile Colitis. Peters H; Iqbal A; Miller E; Khalid S; Rahman O Cureus; 2022 Mar; 14(3):e22872. PubMed ID: 35392442 [TBL] [Abstract][Full Text] [Related]
74. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus. Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621 [TBL] [Abstract][Full Text] [Related]
75. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel. Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951 [TBL] [Abstract][Full Text] [Related]